{'fraction_non_alphanumeric': 0.023943661971830985, 'fraction_numerical': 0.005633802816901409, 'mean_word_length': 5.836538461538462, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Studies on N‐Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators

Individuals with slow N‐acetylation phenotype often experience toxicity from drugs such as isoniazid, sulfonamides, procainamide, and hydralazine, whereas rapid acetylators may not respond to these medications. The highly polymorphic N‐acetyltransferase 2 enzyme encoded by the NAT2 gene is one of the N‐acetylators in humans with a clear impact on the metabolism of a significant number of important drugs. However, there are limited studies on N‐acetylation phenotypes and NAT2 genotypes among Emiratis, and thus this study was carried out to fill this gap.